Despite reducing amyloid plaques, antibody treatments for Alzheimer’s fail to improve cognition, highlighting critical gaps in current therapeutic approaches.
Alzheimer’s monoclonal antibodies fail to deliver meaningful results
- Post author:admin
- Post published:
- Post category:uncategorized